Serum Institute of India buys 50% of Schott Kaisha pharma packaging

Serum secures supply of high-quality pharma packaging

192
Covishield Schott-Kaisha vials
Covishield vaccine in Schott-Kaisha's Type 1 tubular glass vials Photo Schott-Kaisha

Germany’s specialty glass company Schott has a new partner. Serum Institute of India, the world‘s largest vaccine producer and manufacturer of highly-effective biologics, has bought 50% stake in the Indian joint venture Schott Kaisha from former co-owners Kairus Dadachanji and Shapoor Mistry. The joint venture is the leading Indian manufacturer…

Choose your subscription to read more

Trial

0 /mo
Not sure which package to choose? Try full access
  • ₹ 0 for 4 weeks*

PSA Plan 1

1000 /year
Access to the website, weekly eMail newsletter
  • ₹1,000.00 for 1 year*

PSA Plan 2

1500 /Year
Access to the website, weekly eMail newsletter and monthly eMag
  • ₹1500 for Year*

PSA Plan 3

2000 /Year
Print Copy, access to the website, weekly eMail newsletter and monthly eMag
  • ₹2,000.00 for 1 year*